SCHEMBL16339265

SCHEMBL16339265

Cc1ccc(NC(=O)c2cccc3cc[nH]c23)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.64
RAB9A P51151 7/20 0.61
NPC1 O15118 6/20 0.61
KMT2A Q03164 3/20 0.56
MEN1 O00255 2/20 0.56
POLB P06746 2/20 0.56
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP7 Q9BQF6 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
KEAP1 Q14145 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
LMNA P02545 1/20 0.54
TP53 P04637 1/20 0.54
NFKB1 P19838 1/20 0.54
HTT P42858 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
HSD17B10 Q99714 1/20 0.54
PDPK1 O15530 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6219389 0.79 KEAP1 (0.64) GRM5RAB9ANPC1KMT2AMEN1
SCHEMBL1499498 0.78 GRM5 (1.00) GRM5RAB9ANPC1KMT2AMEN1
SCHEMBL678733 0.77 GRM5 (0.70) GRM5RAB9ANPC1KMT2AMEN1
SCHEMBL31358814 0.77 KEAP1 (0.66) GRM5RAB9ANPC1KMT2AMEN1
SCHEMBL678702 0.77 GRM5 (0.66) GRM5RAB9ANPC1KMT2AMEN1
SCHEMBL3790885 0.76 KEAP1 (0.70) GRM5RAB9ANPC1KMT2AMEN1
SCHEMBL30690400 0.76 KEAP1 (0.70) GRM5RAB9ANPC1KMT2AMEN1
SCHEMBL7058035 0.76 RAB9A (0.79) RAB9ANPC1KMT2AMEN1POLB
SCHEMBL8133663 0.76 RAB9A (1.00) RAB9ANPC1KMT2AMEN1POLB
SCHEMBL592306 0.75 GRM5 (0.58) GRM5RAB9ANPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3013337-A1 PRIMARY CARBOXAMIDES AS BTK INHIBITORS Abbvie Inc. (US) 2016-05-04 EP claimed
WO-2014210255-A1 PRIMARY CARBOXAMIDES AS BTK INHIBITORS ABBVIE INC. (US) 2014-12-31 WO claimed
EP-3013337-A1 PRIMARY CARBOXAMIDES AS BTK INHIBITORS Abbvie Inc. (US) 2016-05-04 EP disclosed
WO-2014210255-A1 PRIMARY CARBOXAMIDES AS BTK INHIBITORS ABBVIE INC. (US) 2014-12-31 WO disclosed